COVID - Spplement VACCINE ADJ DISCOVERY PROGRAM (VADP)

NIH RePORTER · NIH · N01 · $3,699,711 · view on reporter.nih.gov ↗

Abstract

To identify the optimal adjuvant for recombinant SARS-CoV2 vaccines, and to identify correlates of protection against SARS-CoV2 infection or disease, experimental SARS-CoV2 vaccines will be formulated with a panel of different vaccine adjuvants and tested side-by-side for immunogenicity and efficacy.

Key facts

NIH application ID: 10301500
Project number: 75N93019C00045-P00003-9999-2
Recipient: UNIVERSITY OF MONTANA
Principal Investigator: JAY EVANS
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $3,699,711
Award type: —
Project period: 2019-09-30 → 2020-09-29